The new UK Life Sciences Vision sets out a mission-led approach with bold ambition for the next decade to ensure scientific excellence, following the UK's life sciences sector's central role in the country's efforts to combat COVID-19 with the Oxford-AstraZeneca vaccine made in Thames Valley's Oxfordshire.
The Vision outlines 7 critical healthcare missions that government, industry, the NHS, academia and medical research charities will work together on at speed to solve – from cancer treatment to tackling dementia.
The missions are:
- Accelerating the pace of studies into novel dementia treatment
- Enabling early diagnosis and treatments, including immune therapies such as cancer vaccines
- Sustaining the UK’s position in vaccine discovery, development and manufacturing
- Treatment and prevention of cardiovascular diseases and its major risk factors, including obesity
- Reducing mortality and morbidity from respiratory disease in the UK and globally
- Addressing the underlying biology of ageing
- Increasing the understanding of mental health conditions, including work to redefine diseases and develop tools to address them
